Spine Guidance 5.4 Software; Spine Guidance 5.4 Upgrade; Spine Guidance 5.4 Update; Spine Guidance 5.4 Software Enable; Spine Guidance 5.4 Sales Demo; Q Drill Tracker; NavLock Adapter; Elite Q Attacments; Elite Cutting Accessories; Maestro Air Motor
Stryker Leibinger GmbH & Co. KG · Decision date Feb 19, 2026
What did the FDA decide?
FDA records K253623 as a 510(k) premarket notification, with a decision dated Feb 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Feb 19, 2026
Regulatory record facts
- Identifier
- K253623
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Stryker Leibinger GmbH & Co. KG
- Product code
- OLO
- Decision code
- SESE
- Decision date
- Feb 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Orthopedic Stereotaxic Instrument.
- Applicant
- Stryker Leibinger GmbH & Co. KG
- Product code
- OLO
- FDA device class
- 2
FDA decision timeline
K253623 received
Application receipt date recorded by FDA.
K253623 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OLO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
GPS AnkleK262567 | Blue Ortho | 510(k) clearance | Oct 26, 2026 | FDA |
7D Surgical System (10-0001)K260403 | 7D Surgical ULC | 510(k) clearance | Oct 19, 2026 | FDA |
| THINK Surgical, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| CarboFix Orhtopedics , Ltd. | 510(k) clearance | Oct 9, 2026 | FDA | |
| Brainlab SE | 510(k) clearance | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Stryker Leibinger GmbH & Co. KG
- Headquarters
- Not reported
- Brand website
- stryker.com
- FDA applicant address
- Freiburg Im Breisgau
Sources and methodology
- Original FDA record: K253623
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



